MetaCap

Collegium Pharmaceutical (COLL) News

NASDAQ: COLLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

24.72-0.49 (-1.94%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

COLL news summary

We found 14 recent headlines mentioning Collegium Pharmaceutical (COLL): 3 in the past week and 12 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, COLL is down 1.94% at $24.72. The most recent story, "J&J to Boost Ophthalmology Pipeline With $2.2B Ollin Acquisition", was published by Nasdaq on Nov 17, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Collegium Pharmaceutical headlines

Stocks mentioned alongside COLL

Compare COLL